The agent storefront at https://agents.pubrio.com/llms.txt?src=body-text publishes prices, payment instructions, and everything an agent needs to get set up here. Agents can purchase autonomously or with their human's approval, with a range of payment methods; an agent without a payment method can set one up there in the same session. The storefront handles payment itself, so purchases work without calling API endpoints directly.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines
Unlock the market timeline & signal feed
1,273 signals in the last 90 days.
The order this company entered each market — oldest to newest
Human Resources Director
Chief Technology Officer
Sign up to see the full signal feed
How Johnson & Johnson's international expansion compares to its competitors
Johnson & JohnsonYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Johnson & JohnsonYou | 54 | 3 | +86% | 1.2k | 40 |
Scaling fast — 1,479 roles opened in the last 90 days, up 40% vs the prior period. Operations-led and concentrated in United States.
Jacksonville, FL · yesterday
Director, Web Product Management
New Brunswick, NJ · yesterday
Director, Web Product Management
Ljubljana, Ljubljana, Slovenia · 2d ago
Business Compliance Manager, Emerging Markets EP
50 technologies detected across the stack.
8 active campaigns across 127 markets.
Ended
Ended
Ended152 mentions in the last 90 days.
Johnson & Johnson reports positive early trial results for JNJ-6143, a new oral cancer therapy.
Johnson & Johnson's experimental prostate cancer drug JNJ-6143 showed significant results in an early-stage trial, with 77% of patients seeing a 50% or more drop in PSA levels.
Wall Street is down, with tech stocks declining due to Meta's non-voting shares announcement and broader market concerns.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Johnson & Johnson's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
